| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d30e202d9b82c32a0f9fc6e40b2f87eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa10d822a1b0a5616994cfef61648ef7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_052d618adbd62c72436eb9ec6f7d08c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eb86884345cbd52aaed4a5ecaf41b55 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate |
2011-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4d8352469f740cc2ae385b8d681a575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a7e8f2666e26966d4f1e70f3904d79c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48f7bd4585c8321fecdeb7643027a731
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e78de190e9da62a8177047eb9919020e |
| publicationDate |
2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012021165-A2 |
| titleOfInvention |
Methods and compositions for treating disorders associated with hyperactive immune system |
| abstract |
The present invention provides methods and compositions for treating disorders associated with hyperactive immune responses. The invention also provides methods for inhibiting activation of CD4 + T cells and/or suppressing proliferation other overactivated T cells (e.g., CD4 . CD8 . T cells). These methods typically involve the administration to the subject a therapeutically effective amount of a compound that inhibits or suppresses IL-7 signaling or IL-15 signaling. |
| priorityDate |
2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |